Tudor Investment Corp’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-19,858
| Closed | -$202K | – | 1929 |
|
|
2025
Q1 | $202K | Buy |
19,858
+4,527
| +30% | +$46.1K | ﹤0.01% | 1406 |
|
|
2024
Q4 | $243K | Sell |
15,331
-4,456
| -23% | -$70.5K | ﹤0.01% | 1371 |
|
|
2024
Q3 | $1.15M | Buy |
19,787
+9,430
| +91% | +$548K | ﹤0.01% | 966 |
|
|
2024
Q2 | $473K | Sell |
10,357
-6,646
| -39% | -$304K | ﹤0.01% | 1208 |
|
|
2024
Q1 | $1.13M | Buy |
17,003
+7,560
| +80% | +$500K | 0.01% | 846 |
|
|
2023
Q4 | $375K | Buy |
+9,443
| New | +$375K | ﹤0.01% | 1205 |
|
|
2023
Q2 | – | Sell |
-17,666
| Closed | -$754K | – | 1775 |
|
|
2023
Q1 | $754K | Buy |
+17,666
| New | +$754K | 0.01% | 1011 |
|
|
2022
Q4 | – | Sell |
-12,829
| Closed | -$483K | – | 1779 |
|
|
2022
Q3 | $483K | Buy |
12,829
+636
| +5% | +$23.9K | 0.01% | 1122 |
|
|
2022
Q2 | $337K | Buy |
+12,193
| New | +$337K | 0.01% | 1202 |
|